GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 733 filers reported holding GLAXOSMITHKLINE PLC in Q4 2014. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $915,000 | -20.4% | 21,021 | -20.4% | 0.03% | -11.1% |
Q1 2022 | $1,150,000 | +23.8% | 26,410 | +25.4% | 0.04% | +28.6% |
Q4 2021 | $929,000 | +31.6% | 21,063 | +14.1% | 0.03% | +16.7% |
Q3 2021 | $706,000 | +17.7% | 18,457 | +22.6% | 0.02% | +14.3% |
Q2 2021 | $600,000 | +14.3% | 15,054 | +2.3% | 0.02% | +10.5% |
Q1 2021 | $525,000 | -17.8% | 14,720 | -15.2% | 0.02% | -24.0% |
Q4 2020 | $639,000 | -0.5% | 17,355 | +1.7% | 0.02% | -10.7% |
Q3 2020 | $642,000 | -10.1% | 17,062 | -2.5% | 0.03% | -17.6% |
Q2 2020 | $714,000 | +18.2% | 17,507 | +9.8% | 0.03% | -2.9% |
Q1 2020 | $604,000 | -31.4% | 15,941 | -15.0% | 0.04% | -12.5% |
Q4 2019 | $881,000 | +14.9% | 18,760 | +4.3% | 0.04% | +11.1% |
Q3 2019 | $767,000 | +7.1% | 17,984 | +0.5% | 0.04% | +5.9% |
Q2 2019 | $716,000 | -5.3% | 17,896 | -1.1% | 0.03% | -12.8% |
Q1 2019 | $756,000 | +18.3% | 18,086 | +8.1% | 0.04% | +5.4% |
Q4 2018 | $639,000 | -11.0% | 16,736 | -6.4% | 0.04% | 0.0% |
Q3 2018 | $718,000 | +1.1% | 17,871 | +1.5% | 0.04% | -5.1% |
Q2 2018 | $710,000 | +48.2% | 17,607 | +43.5% | 0.04% | +44.4% |
Q1 2018 | $479,000 | +24.1% | 12,270 | +12.9% | 0.03% | +28.6% |
Q4 2017 | $386,000 | -6.5% | 10,869 | +6.9% | 0.02% | -8.7% |
Q3 2017 | $413,000 | -8.4% | 10,163 | -6.2% | 0.02% | -30.3% |
Q2 2017 | $451,000 | +3.9% | 10,838 | +5.3% | 0.03% | +6.5% |
Q1 2017 | $434,000 | +9.0% | 10,289 | -0.4% | 0.03% | 0.0% |
Q4 2016 | $398,000 | -5.5% | 10,332 | +5.9% | 0.03% | -8.8% |
Q3 2016 | $421,000 | -0.5% | 9,752 | 0.0% | 0.03% | -5.6% |
Q2 2016 | $423,000 | -3.2% | 9,752 | -9.5% | 0.04% | -5.3% |
Q1 2016 | $437,000 | +18.4% | 10,777 | +17.8% | 0.04% | +5.6% |
Q4 2015 | $369,000 | -6.6% | 9,146 | -11.1% | 0.04% | -12.2% |
Q3 2015 | $395,000 | +7.3% | 10,292 | +16.5% | 0.04% | +13.9% |
Q2 2015 | $368,000 | -10.5% | 8,837 | -0.8% | 0.04% | -10.0% |
Q1 2015 | $411,000 | +7.3% | 8,910 | -0.4% | 0.04% | -9.1% |
Q4 2014 | $383,000 | – | 8,946 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |